首页 > 最新文献

Revista da Associacao Medica Brasileira (1992)最新文献

英文 中文
Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion. 泮托拉唑对心肌缺血再灌注Wistar大鼠的心脏毒性作用。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20251415
Adilson Costa Dos Santos, Celia Maria Camelo Silva, Erisvaldo Amarante de Araújo, Lucas de Oliveira Sassi, Adriano Caixeta, Murched Omar Taha, Marcelo Pires-Oliveira, Afonso Caricati-Neto, Renato Delascio Lopes, Fernando Sabia Tallo, Francisco Sandro Menezes-Rodrigues

Objective: The aim of the study was to evaluate the cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion.

Methods: Cardiac ischemia and reperfusion was induced in rats through tourniquet of the left anterior descending coronary artery (10 min) followed by reperfusion (75 min). The incidences of ventricular arrhythmias, atrioventricular block, and lethality were evaluated by electrocardiogram analysis and compared between the control group (saline solution+cardiac ischemia and reperfusion) and the animals treated with pantoprazole 36 mg/kg (pantoprazole+cardiac ischemia and reperfusion), intravenously, immediately before cardiac ischemia (pantoprazole+cardiac ischemia and reperfusion) or before cardiac reperfusion (pantoprazole+cardiac reperfusion).

Results: There were no differences between the incidences of ventricular arrhythmias in the groups studied. Treatment with pantoprazole before cardiac ischemia and reperfusion increased the incidence of atrioventricular block and lethality and myocardial injuries compared to the saline solution+cardiac ischemia and reperfusion group, but treatment of animals with pantoprazole before cardiac reperfusion decreased these parameters and serum creatine kinase-MB levels.

Conclusion: Our results indicate that when pantoprazole is administered before cardiac ischemia and reperfusion, it promotes cardiotoxicity; however, when administered before cardiac reperfusion, it promotes cardioprotection in Wistar rats.

目的:研究泮托拉唑对心肌缺血再灌注Wistar大鼠的心脏毒性作用。方法:采用冠状动脉左前降支止血带法(10 min)诱导大鼠心肌缺血再灌注(75 min)。通过心电图分析评估对照组(生理盐水+心脏缺血再灌注)与泮托拉唑36 mg/kg(泮托拉唑+心脏缺血再灌注)、静脉、缺血前(泮托拉唑+心脏缺血再灌注)、心脏再灌注前(泮托拉唑+心脏再灌注)各组动物室性心律失常、房室传导阻滞及死亡率的发生率。结果:两组间室性心律失常发生率无差异。与生理盐水+心肌缺血再灌注组相比,心脏缺血再灌注前泮托拉唑治疗增加了房室传导阻滞、死亡率和心肌损伤的发生率,但心脏再灌注前泮托拉唑治疗降低了这些参数和血清肌酸激酶- mb水平。结论:心脏缺血再灌注前给药泮托拉唑可促进心脏毒性;然而,当在心脏再灌注前给药时,它可以促进Wistar大鼠的心脏保护。
{"title":"Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion.","authors":"Adilson Costa Dos Santos, Celia Maria Camelo Silva, Erisvaldo Amarante de Araújo, Lucas de Oliveira Sassi, Adriano Caixeta, Murched Omar Taha, Marcelo Pires-Oliveira, Afonso Caricati-Neto, Renato Delascio Lopes, Fernando Sabia Tallo, Francisco Sandro Menezes-Rodrigues","doi":"10.1590/1806-9282.20251415","DOIUrl":"10.1590/1806-9282.20251415","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study was to evaluate the cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion.</p><p><strong>Methods: </strong>Cardiac ischemia and reperfusion was induced in rats through tourniquet of the left anterior descending coronary artery (10 min) followed by reperfusion (75 min). The incidences of ventricular arrhythmias, atrioventricular block, and lethality were evaluated by electrocardiogram analysis and compared between the control group (saline solution+cardiac ischemia and reperfusion) and the animals treated with pantoprazole 36 mg/kg (pantoprazole+cardiac ischemia and reperfusion), intravenously, immediately before cardiac ischemia (pantoprazole+cardiac ischemia and reperfusion) or before cardiac reperfusion (pantoprazole+cardiac reperfusion).</p><p><strong>Results: </strong>There were no differences between the incidences of ventricular arrhythmias in the groups studied. Treatment with pantoprazole before cardiac ischemia and reperfusion increased the incidence of atrioventricular block and lethality and myocardial injuries compared to the saline solution+cardiac ischemia and reperfusion group, but treatment of animals with pantoprazole before cardiac reperfusion decreased these parameters and serum creatine kinase-MB levels.</p><p><strong>Conclusion: </strong>Our results indicate that when pantoprazole is administered before cardiac ischemia and reperfusion, it promotes cardiotoxicity; however, when administered before cardiac reperfusion, it promotes cardioprotection in Wistar rats.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20251415"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of neonatal cerebral oxygenation using near-infrared spectroscopy in cesarean sections performed with neuraxial blocks: a prospective randomized clinical trial. 使用近红外光谱评估新生儿脑氧合在剖宫产行神经轴阻滞:一项前瞻性随机临床试验。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20250678
Ahsen Gur Celık, Derya Karasu, Nermin Kılıçarslan, Canan Yılmaz, Aycan Kurtarangıl Dogan, Gurcan Guler, Seyda Efsun Ozgunay, Mehmet Gamlı

Objective: The aim of the study was to evaluate the effects of epidural and spinal anesthesia techniques on neonatal cerebral oxygenation during cesarean surgery using near-infrared spectroscopy.

Methods: Pregnant women aged 18-35 years, classified as American Society of Anesthesiologists (ASA) II, scheduled for elective cesarean surgery at >37 weeks of gestation, and their newborns were included. Two groups, one to receive spinal anesthesia (Group S) and the other epidural anesthesia (Group E), were determined. Appearance Pulse Grimace Acitivity Respiration (APGAR) scores, heart rates, and SpO2 values of the newborns were recorded, and umbilical venous blood gas was collected. Near-infrared spectroscopy and rSO2 (regional cerebral oxygen saturation) change percentage were measured.

Results: A total of 80 patients were statistically analyzed, with 40 patients in Group S and 40 patients in Group E. Neonatal SpO2 values at 2.5 min were found to be significantly lower in Group S, while in blood gas parameters, PaO2 values were significantly lower in Group S. Near-infrared spectroscopy values at 2.5 and 5 min were significantly lower in Group S, and rSO2 change percentages were significantly lower at 2.5 min in Group S. Maternal hypotension was observed to be significantly higher in Group S (52.5%) than in Group E (22.5%). The amount of ephedrine administered until delivery was higher in Group S, but this difference was not statistically significant between the two groups.

Conclusion: We found significantly lower near-infrared spectroscopy values at 2.5 and 5 min and rSO2 change percentage at 2.5 min in the spinal group. We believe that epidural anesthesia has minimally more positive effects on early neonatal cerebral oxygenation compared to spinal anesthesia.

目的:应用近红外光谱技术评价剖宫产术中硬膜外麻醉和脊髓麻醉对新生儿脑氧合的影响。方法:年龄18 ~ 35岁,美国麻醉学会(ASA) II级,妊娠50 ~ 37周行择期剖宫产手术的孕妇及其新生儿。分为脊髓麻醉组(S组)和硬膜外麻醉组(E组)。记录新生儿APGAR评分、心率、SpO2值,并采集脐静脉血气。测定近红外光谱和区域脑氧饱和度(rSO2)变化百分比。结果:统计分析80例患者,其中S组40例,e组40例。新生儿SpO2值在2.5 min时S组显著降低,血气参数中,PaO2值S组显著降低,2.5、5 min时S组近红外光谱值显著降低;在2.5 min时,S组的rSO2变化百分比明显低于E组(22.5%),S组的低血压发生率明显高于E组(52.5%)。S组给药至分娩的麻黄碱量较高,但两组间差异无统计学意义。结论:脊柱组2.5 min、5 min近红外光谱值及2.5 min rSO2变化率明显降低。我们认为硬膜外麻醉对早期新生儿脑氧合的积极作用比脊髓麻醉要少。
{"title":"Assessment of neonatal cerebral oxygenation using near-infrared spectroscopy in cesarean sections performed with neuraxial blocks: a prospective randomized clinical trial.","authors":"Ahsen Gur Celık, Derya Karasu, Nermin Kılıçarslan, Canan Yılmaz, Aycan Kurtarangıl Dogan, Gurcan Guler, Seyda Efsun Ozgunay, Mehmet Gamlı","doi":"10.1590/1806-9282.20250678","DOIUrl":"10.1590/1806-9282.20250678","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study was to evaluate the effects of epidural and spinal anesthesia techniques on neonatal cerebral oxygenation during cesarean surgery using near-infrared spectroscopy.</p><p><strong>Methods: </strong>Pregnant women aged 18-35 years, classified as American Society of Anesthesiologists (ASA) II, scheduled for elective cesarean surgery at >37 weeks of gestation, and their newborns were included. Two groups, one to receive spinal anesthesia (Group S) and the other epidural anesthesia (Group E), were determined. Appearance Pulse Grimace Acitivity Respiration (APGAR) scores, heart rates, and SpO2 values of the newborns were recorded, and umbilical venous blood gas was collected. Near-infrared spectroscopy and rSO2 (regional cerebral oxygen saturation) change percentage were measured.</p><p><strong>Results: </strong>A total of 80 patients were statistically analyzed, with 40 patients in Group S and 40 patients in Group E. Neonatal SpO2 values at 2.5 min were found to be significantly lower in Group S, while in blood gas parameters, PaO2 values were significantly lower in Group S. Near-infrared spectroscopy values at 2.5 and 5 min were significantly lower in Group S, and rSO2 change percentages were significantly lower at 2.5 min in Group S. Maternal hypotension was observed to be significantly higher in Group S (52.5%) than in Group E (22.5%). The amount of ephedrine administered until delivery was higher in Group S, but this difference was not statistically significant between the two groups.</p><p><strong>Conclusion: </strong>We found significantly lower near-infrared spectroscopy values at 2.5 and 5 min and rSO2 change percentage at 2.5 min in the spinal group. We believe that epidural anesthesia has minimally more positive effects on early neonatal cerebral oxygenation compared to spinal anesthesia.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20250678"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polymorphisms in the proprotein convertase subtilisin/kexin type 9 gene in clinically diagnosed patients with familial hypercholesterolemia. 家族性高胆固醇血症临床诊断患者蛋白转化酶枯草菌素/kexin 9型基因多态性
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20250873
Aldrina Laura da Silva Costa, José Ernesto Dos Santos, Wilson Salgado Junior, Caroline Bertoncini-Silva, Letícia Bizari, Gustavo Santos Paiva Laender Moura, Raphael Del Roio Liberatore Junior, Renato Augusto Zorzo, Vivian Marques Miguel Suen

Objective: The aim of this study was to investigate polymorphisms in the proprotein convertase subtilisin/kexin type 9 gene and compare disease severity in familial hypercholesterolemia participants with and without these polymorphisms.

Methods: Fifty patients were included in this observational, cross-sectional study of primary data collection between June 2014 and June 2015 at Clinics Hospital of Ribeirão Preto Medical School/University of São Paulo Inclusion criteria for the study included individuals with an low-density lipoprotein cholesterol level ≥190 mg/dL, based on Dutch make early diagnosis prevent early death criteria for familial hypercholesterolemia. Patients with kidney disease, liver failure, a triglyceride level ≥300 mg/dL, or hypothyroidism were excluded. Gene analysis was performed using the high-resolution melting method. deoxyribonucleic acid samples with detected changes were sequenced to identify polymorphisms. Lipid profile, body mass index, history of cardiovascular events, gender, and statin use were compared between participants with and without polymorphisms.

Results: Of the 50 patients, 14 carried proprotein convertase subtilisin/kexin type 9 polymorphisms. Familial hypercholesterolemia was not associated with these polymorphisms in this cohort. As gene expression was not assessed, no conclusions can be drawn regarding functional effects. Six patients (four in the polymorphism group and two in the non-polymorphism group) reported cardiovascular events. The significantly higher occurrence of these events in the polymorphism group suggests a possible association between the presence of proprotein convertase subtilisin/kexin type 9 polymorphisms and an increased cardiovascular risk.

Conclusion: Benign variants were identified in the proprotein convertase subtilisin/kexin type 9 gene, with no pathogenic alterations detected. Despite the significantly higher number of participants with a history of cardiovascular events in the polymorphism group, these data do not support a direct, causal association between these polymorphisms and an increased cardiovascular risk.

目的:本研究的目的是研究蛋白转化酶枯草菌素/ keexin 9型基因的多态性,并比较家族性高胆固醇血症患者有和没有这些多态性的疾病严重程度。方法:这项观察性横断面研究纳入了2014年6月至2015年6月期间在ribebereo Preto医学院/ 圣保罗大学诊所医院收集的50例患者,主要数据收集于2014年6月至2015年6月。研究纳入标准包括低密度脂蛋白胆固醇水平≥190 mg/dL的个体,基于荷兰家族性高胆固醇血症的早期诊断预防早死标准。排除有肾脏疾病、肝功能衰竭、甘油三酯水平≥300 mg/dL或甲状腺功能减退的患者。采用高分辨率熔融法进行基因分析。对检测到变化的脱氧核糖核酸样本进行测序以确定多态性。脂质谱、体重指数、心血管事件史、性别和他汀类药物的使用在有和没有多态性的参与者之间进行比较。结果:50例患者中,14例携带枯草杆菌蛋白转化酶/ keexin 9型多态性。在该队列中,家族性高胆固醇血症与这些多态性无关。由于没有评估基因表达,因此无法得出有关功能影响的结论。6名患者(多态性组4名,非多态性组2名)报告了心血管事件。多态性组中这些事件的发生率明显较高,这表明蛋白转化酶枯草杆菌素/ keexin 9型多态性的存在与心血管风险增加之间可能存在关联。结论:蛋白转化酶枯草素/kexin 9型基因存在良性变异,未发现致病性改变。尽管多态性组中有心血管事件史的参与者数量明显增加,但这些数据并不支持这些多态性与心血管风险增加之间的直接因果关系。
{"title":"Polymorphisms in the proprotein convertase subtilisin/kexin type 9 gene in clinically diagnosed patients with familial hypercholesterolemia.","authors":"Aldrina Laura da Silva Costa, José Ernesto Dos Santos, Wilson Salgado Junior, Caroline Bertoncini-Silva, Letícia Bizari, Gustavo Santos Paiva Laender Moura, Raphael Del Roio Liberatore Junior, Renato Augusto Zorzo, Vivian Marques Miguel Suen","doi":"10.1590/1806-9282.20250873","DOIUrl":"10.1590/1806-9282.20250873","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate polymorphisms in the proprotein convertase subtilisin/kexin type 9 gene and compare disease severity in familial hypercholesterolemia participants with and without these polymorphisms.</p><p><strong>Methods: </strong>Fifty patients were included in this observational, cross-sectional study of primary data collection between June 2014 and June 2015 at Clinics Hospital of Ribeirão Preto Medical School/University of São Paulo Inclusion criteria for the study included individuals with an low-density lipoprotein cholesterol level ≥190 mg/dL, based on Dutch make early diagnosis prevent early death criteria for familial hypercholesterolemia. Patients with kidney disease, liver failure, a triglyceride level ≥300 mg/dL, or hypothyroidism were excluded. Gene analysis was performed using the high-resolution melting method. deoxyribonucleic acid samples with detected changes were sequenced to identify polymorphisms. Lipid profile, body mass index, history of cardiovascular events, gender, and statin use were compared between participants with and without polymorphisms.</p><p><strong>Results: </strong>Of the 50 patients, 14 carried proprotein convertase subtilisin/kexin type 9 polymorphisms. Familial hypercholesterolemia was not associated with these polymorphisms in this cohort. As gene expression was not assessed, no conclusions can be drawn regarding functional effects. Six patients (four in the polymorphism group and two in the non-polymorphism group) reported cardiovascular events. The significantly higher occurrence of these events in the polymorphism group suggests a possible association between the presence of proprotein convertase subtilisin/kexin type 9 polymorphisms and an increased cardiovascular risk.</p><p><strong>Conclusion: </strong>Benign variants were identified in the proprotein convertase subtilisin/kexin type 9 gene, with no pathogenic alterations detected. Despite the significantly higher number of participants with a history of cardiovascular events in the polymorphism group, these data do not support a direct, causal association between these polymorphisms and an increased cardiovascular risk.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20250873"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal diagnosis to postnatal outcomes in multicystic dysplastic kidney: experience of a tertiary center in the Black Sea region. 多囊性发育不良肾的产前诊断到产后结局:黑海地区一个三级中心的经验。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20251175
Gökhan Ünver, Sercan Serin, Miğraci Tosun, Handan Çelik, Mesut Önal, Ümmet Abur, Engin Altundağ

Objective: The aim of this study was to determine the association of unilateral multicystic dysplastic kidney in fetuses with genetic disorders, syndromic conditions, accompanying anatomical anomalies, and postnatal prognosis.

Methods: Cases diagnosed with multicystic dysplastic kidney and followed at the Perinatology Clinic of Samsun Ondokuz Mayıs University between January 2012 and June 2024 were retrospectively reviewed. Demographic, ultrasonographic, genetic, and postnatal outcomes were analyzed.

Results: Thirty-eight fetuses with multicystic dysplastic kidney were identified during intrauterine life. The diagnosis was made via antenatal ultrasonography in 97.2% of cases. Laterality was on the left side in 55.3% and on the right side in 44.7% of multicystic dysplastic kidney cases. The cohort consisted of 42.1% females and 57.9% males. Major extrarenal anomalies were present in 21.1% of fetuses with unilateral multicystic dysplastic kidney. Amniocentesis for karyotyping was performed in 23.7% of cases, all of which yielded normal karyotypes. Contralateral kidney anomalies were detected in 13.2% of cases, and ureterocele was observed in 15.8%. The most common postnatal anomalies were ureteropelvic junction obstruction and grade four-five vesicoureteral reflux. During a mean follow-up period of 7 years, no cases of hypertension or Wilms tumor were identified.

Conclusion: Prenatal diagnosis of multicystic dysplastic kidney is crucial for early detection of potential contralateral kidney anomalies and predicting postnatal outcomes. In cases of isolated multicystic dysplastic kidney, the likelihood of karyotypic abnormalities, malignancies, or hypertension is very low, and the postnatal prognosis is favorable.

目的:本研究的目的是确定胎儿单侧多囊肾发育不良与遗传疾病、综合征条件、伴随解剖异常和出生后预后的关系。方法:回顾性分析2012年1月至2024年6月在Samsun Ondokuz Mayıs大学围产期诊所诊断为多囊性发育不良肾脏并随访的病例。分析了人口统计学、超声检查、遗传学和产后结果。结果:38例宫内多囊肾发育不良胎儿。97.2%的病例通过产前超声诊断。在多囊性发育不良肾病例中,左侧为55.3%,右侧为44.7%。该队列由42.1%的女性和57.9%的男性组成。单侧多囊肾发育不良胎儿中有21.1%存在主要的肾外异常。23.7%的病例行羊膜穿刺术进行核型分析,核型均为正常。对侧肾脏异常占13.2%,输尿管膨出占15.8%。最常见的产后异常是输尿管肾盂连接处梗阻和4 - 5级膀胱输尿管反流。在平均7年的随访期间,未发现高血压或肾母细胞瘤病例。结论:多囊性发育不良肾的产前诊断对早期发现对侧肾异常和预测产后预后具有重要意义。在孤立性多囊性发育不良肾的病例中,核型异常、恶性肿瘤或高血压的可能性非常低,产后预后良好。
{"title":"Prenatal diagnosis to postnatal outcomes in multicystic dysplastic kidney: experience of a tertiary center in the Black Sea region.","authors":"Gökhan Ünver, Sercan Serin, Miğraci Tosun, Handan Çelik, Mesut Önal, Ümmet Abur, Engin Altundağ","doi":"10.1590/1806-9282.20251175","DOIUrl":"10.1590/1806-9282.20251175","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to determine the association of unilateral multicystic dysplastic kidney in fetuses with genetic disorders, syndromic conditions, accompanying anatomical anomalies, and postnatal prognosis.</p><p><strong>Methods: </strong>Cases diagnosed with multicystic dysplastic kidney and followed at the Perinatology Clinic of Samsun Ondokuz Mayıs University between January 2012 and June 2024 were retrospectively reviewed. Demographic, ultrasonographic, genetic, and postnatal outcomes were analyzed.</p><p><strong>Results: </strong>Thirty-eight fetuses with multicystic dysplastic kidney were identified during intrauterine life. The diagnosis was made via antenatal ultrasonography in 97.2% of cases. Laterality was on the left side in 55.3% and on the right side in 44.7% of multicystic dysplastic kidney cases. The cohort consisted of 42.1% females and 57.9% males. Major extrarenal anomalies were present in 21.1% of fetuses with unilateral multicystic dysplastic kidney. Amniocentesis for karyotyping was performed in 23.7% of cases, all of which yielded normal karyotypes. Contralateral kidney anomalies were detected in 13.2% of cases, and ureterocele was observed in 15.8%. The most common postnatal anomalies were ureteropelvic junction obstruction and grade four-five vesicoureteral reflux. During a mean follow-up period of 7 years, no cases of hypertension or Wilms tumor were identified.</p><p><strong>Conclusion: </strong>Prenatal diagnosis of multicystic dysplastic kidney is crucial for early detection of potential contralateral kidney anomalies and predicting postnatal outcomes. In cases of isolated multicystic dysplastic kidney, the likelihood of karyotypic abnormalities, malignancies, or hypertension is very low, and the postnatal prognosis is favorable.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20251175"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of genital self-image on sexual function and sexual satisfaction in married women. 已婚女性生殖器自我形象对性功能和性满意度的影响。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20250935
Yurdagül Günaydin, Esma Kir, Serpil Toker, Medine Kir Deprem

Objective: This study was conducted to determine the effect of genital self-image on sexual function and satisfaction in married women.

Methods: The study included 353 married women in Central Anatolia. Data were collected using the Descriptive Information Form, the Female Genital Self-Image Scale, the Female Sexual Function Index-6, and the Golombok-Rust Inventory of Sexual Satisfaction.

Results: The participants' mean total scores were 20.36±4.03 on the Female Genital Self-Image Scale, 19.46±4.98 on the Female Sexual Function Index-6, and 55.84±16.79 on the Golombok-Rust Inventory of Sexual Satisfaction. The regression analysis indicated that Female Sexual Function Index-6, age, marriage duration, and total Golombok-Rust Inventory of Sexual Satisfaction scores collectively predicted Female Genital Self-Image Scale scores, accounting for 13.2% of variance and suggesting a modest yet meaningful effect.

Conclusion: Approaches that enhance genital self-image support women's sexual health, and it is essential for healthcare professionals to provide quality care by taking these factors into consideration.

目的:探讨已婚女性生殖器自我形象对性功能和性满意度的影响。方法:研究对象为中部安纳托利亚地区353名已婚妇女。采用描述性信息表、女性生殖器自我形象量表、女性性功能指数-6和Golombok-Rust性满意度量表收集数据。结果:女性生殖器自我形象量表得分为20.36±4.03分,女性性功能指数-6得分为19.46±4.98分,性满意度量表得分为55.84±16.79分。回归分析表明,女性性功能指数-6、年龄、婚姻持续时间和Golombok-Rust性满意度总量表得分共同预测女性生殖器自我形象量表得分,占方差的13.2%,提示适度但有意义的影响。结论:增强女性生殖器自我形象的方法有助于女性性健康,医护人员必须考虑到这些因素,提供高质量的护理。
{"title":"The impact of genital self-image on sexual function and sexual satisfaction in married women.","authors":"Yurdagül Günaydin, Esma Kir, Serpil Toker, Medine Kir Deprem","doi":"10.1590/1806-9282.20250935","DOIUrl":"10.1590/1806-9282.20250935","url":null,"abstract":"<p><strong>Objective: </strong>This study was conducted to determine the effect of genital self-image on sexual function and satisfaction in married women.</p><p><strong>Methods: </strong>The study included 353 married women in Central Anatolia. Data were collected using the Descriptive Information Form, the Female Genital Self-Image Scale, the Female Sexual Function Index-6, and the Golombok-Rust Inventory of Sexual Satisfaction.</p><p><strong>Results: </strong>The participants' mean total scores were 20.36±4.03 on the Female Genital Self-Image Scale, 19.46±4.98 on the Female Sexual Function Index-6, and 55.84±16.79 on the Golombok-Rust Inventory of Sexual Satisfaction. The regression analysis indicated that Female Sexual Function Index-6, age, marriage duration, and total Golombok-Rust Inventory of Sexual Satisfaction scores collectively predicted Female Genital Self-Image Scale scores, accounting for 13.2% of variance and suggesting a modest yet meaningful effect.</p><p><strong>Conclusion: </strong>Approaches that enhance genital self-image support women's sexual health, and it is essential for healthcare professionals to provide quality care by taking these factors into consideration.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20250935"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons from public health policies contributing to Brazil's lowest maternal mortality ratio in 2022: a short communication. 公共卫生政策的教训有助于巴西在2022年实现最低的孕产妇死亡率:简短的沟通。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20251688
Raphael Câmara Medeiros Parente, Marcelo Antônio Cartaxo Queiroga Lopes, Lana de Lourdes Aguiar Lima, Patrícia Marçal
{"title":"Lessons from public health policies contributing to Brazil's lowest maternal mortality ratio in 2022: a short communication.","authors":"Raphael Câmara Medeiros Parente, Marcelo Antônio Cartaxo Queiroga Lopes, Lana de Lourdes Aguiar Lima, Patrícia Marçal","doi":"10.1590/1806-9282.20251688","DOIUrl":"10.1590/1806-9282.20251688","url":null,"abstract":"","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20251688"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Misoprostol combined with artificial membrane stripping showed the best effect of induction among women with gestational diabetes mellitus: a retrospective cohort study. 米索前列醇联合人工膜剥离对妊娠期糖尿病患者的诱导效果最好:一项回顾性队列研究。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20251162
Xuemei Li, Qimei Yang, Xia Zhang, Lidan He, Jianbo Wu

Objective: The aim of this study was to explore the optimal method of induction of labor in women with gestational diabetes mellitus and its impact on delivery outcomes.

Methods: This retrospective cohort study was conducted among nulliparous women with gestational diabetes mellitus delivering at the First Affiliated Hospital of Fujian Medical University and the First People's Hospital of Yunnan Province from 2018 to 2023. Data were extracted from electronic medical records.

Results: A total of 600 patients who delivered met the inclusion criteria: the double-balloon group (Group B, n=198), the misoprostol vaginal insert group (Group M, n=200), and the Misoprostol combined with artificial membrane stripping group (Group MA, n=202). Group MA showed higher induction of labor success rates (93.5%) compared to Group M (86.0%) and Group B (81.5%, p=0.002). The time to labor onset was shortest in Group MA (32.5±6.5 h), followed by Group M (35.8±2.5 h) and Group B (45.8±4.5 h, p<0.001). Vaginal delivery time was also significantly shorter in Group MA (47.4±4.3 h) compared to Group M (49.1±7.4 h) and Group B (57.1±5.7 h, p<0.001). Chorioamnionitis rates were lower in Group MA (2.5%) and Group M (3.0%) compared to Group B (8.5%, p=0.007). No significant differences were observed between groups for cesarean rates, fetal distress, abnormal labor, or neonatal outcomes (p>0.05).

Conclusion: The combination of misoprostol vaginal insert and artificial membrane stripping effectively enhances cervical ripening and improves vaginal delivery success in gestational diabetes mellitus patients, providing a promising strategy for labor induction.

目的:探讨妊娠期糖尿病患者的最佳引产方法及其对分娩结局的影响。方法:回顾性队列研究2018 - 2023年在福建医科大学第一附属医院和云南省第一人民医院分娩的未产妊娠期糖尿病妇女。数据从电子病历中提取。结果:共600例分娩患者符合纳入标准:双气囊组(B组,n=198)、米索前列醇阴道插入组(M组,n=200)、米索前列醇联合人工膜剥离组(MA组,n=202)。MA组引产成功率(93.5%)高于M组(86.0%)和B组(81.5%,p=0.002)。MA组分娩时间最短(32.5±6.5 h),其次为M组(35.8±2.5 h)和B组(45.8±4.5 h), p < 0.05)。结论:米索前列醇阴道插入联合人工膜剥离可有效促进妊娠期糖尿病患者宫颈成熟,提高阴道分娩成功率,是一种有前景的引产策略。
{"title":"Misoprostol combined with artificial membrane stripping showed the best effect of induction among women with gestational diabetes mellitus: a retrospective cohort study.","authors":"Xuemei Li, Qimei Yang, Xia Zhang, Lidan He, Jianbo Wu","doi":"10.1590/1806-9282.20251162","DOIUrl":"10.1590/1806-9282.20251162","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to explore the optimal method of induction of labor in women with gestational diabetes mellitus and its impact on delivery outcomes.</p><p><strong>Methods: </strong>This retrospective cohort study was conducted among nulliparous women with gestational diabetes mellitus delivering at the First Affiliated Hospital of Fujian Medical University and the First People's Hospital of Yunnan Province from 2018 to 2023. Data were extracted from electronic medical records.</p><p><strong>Results: </strong>A total of 600 patients who delivered met the inclusion criteria: the double-balloon group (Group B, n=198), the misoprostol vaginal insert group (Group M, n=200), and the Misoprostol combined with artificial membrane stripping group (Group MA, n=202). Group MA showed higher induction of labor success rates (93.5%) compared to Group M (86.0%) and Group B (81.5%, p=0.002). The time to labor onset was shortest in Group MA (32.5±6.5 h), followed by Group M (35.8±2.5 h) and Group B (45.8±4.5 h, p<0.001). Vaginal delivery time was also significantly shorter in Group MA (47.4±4.3 h) compared to Group M (49.1±7.4 h) and Group B (57.1±5.7 h, p<0.001). Chorioamnionitis rates were lower in Group MA (2.5%) and Group M (3.0%) compared to Group B (8.5%, p=0.007). No significant differences were observed between groups for cesarean rates, fetal distress, abnormal labor, or neonatal outcomes (p>0.05).</p><p><strong>Conclusion: </strong>The combination of misoprostol vaginal insert and artificial membrane stripping effectively enhances cervical ripening and improves vaginal delivery success in gestational diabetes mellitus patients, providing a promising strategy for labor induction.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20251162"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination of cyclin-dependent kinase 4/6 inhibitors and renin-angiotensin system inhibitors in breast cancer treatment: a promising therapeutic approach. 周期蛋白依赖性激酶4/6抑制剂和肾素-血管紧张素系统抑制剂联合治疗乳腺癌:一种有前途的治疗方法。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20251164
Emel Mutlu, Mevlüde İnanç

Objective: The prognosis of metastatic breast cancer has improved with new targeted therapies like cyclin-dependent kinase 4/6 inhibitors. Renin-angiotensin system inhibitors, such as direct renin inhibitors, angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors are frequently used to manage hypertension and heart failure. However, recent research indicates that they may also provide potential benefits in cancer therapy. The combination of renin-angiotensin system inhibitors with cyclin-dependent kinase 4/6 inhibitors is an emerging area of interest in cancer research. Our hypotesis that, by inhibiting angiogenesis, renin-angiotensin system inhibitors may reduce tumor growth and improve the effectiveness of cyclin-dependent kinase 4/6 inhibitors by cutting off the supply of nutrients and oxygen to the tumor.

Methods: Metastatic breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors were enrolled and retrospectively divided according to angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (+) and angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (-). Progression-free survival and overall survival were defined as primary and secondary endpoints. The effect of categorized data on progression-free survival and overall survival was determined by Cox regression analyses.

Results: Estimated median progression-free survival (HR 0.61, 95%CI 0.34-0.94; p = 0.041) and overall survival (HR 0.71, 95%CI 0.49-0.79; p: 0.01) were statistically significantly longer in the angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (+) group than in the angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (-) group.

Conclusion: Concomitant use of renin-angiotensin system inhibitors and cyclin-dependent kinase 4/6 inhibitors may have beneficial oncological effects in patients with breast cancer beyond their cardiovascular indications.

目的:周期蛋白依赖性激酶4/6抑制剂等新的靶向治疗方法改善了转移性乳腺癌的预后。肾素-血管紧张素系统抑制剂,如直接肾素抑制剂,血管紧张素II受体阻滞剂和血管紧张素转换酶抑制剂经常用于治疗高血压和心力衰竭。然而,最近的研究表明,它们也可能在癌症治疗中提供潜在的益处。肾素-血管紧张素系统抑制剂与细胞周期蛋白依赖性激酶4/6抑制剂的联合使用是癌症研究中一个新兴的研究领域。我们的假设是,通过抑制血管生成,肾素-血管紧张素系统抑制剂可以减少肿瘤生长,并通过切断肿瘤的营养和氧气供应来提高周期蛋白依赖性激酶4/6抑制剂的有效性。方法:采用细胞周期蛋白依赖性激酶4/6抑制剂治疗的转移性乳腺癌患者,按照使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂(+)和血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂(-)回顾性分为血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂。无进展生存期和总生存期被定义为主要和次要终点。分类数据对无进展生存期和总生存期的影响通过Cox回归分析确定。结果:血管紧张素转换酶抑制剂/血管紧张素II受体阻滞剂(+)组的估计中位无进展生存期(HR 0.61, 95%CI 0.34-0.94; p = 0.041)和总生存期(HR 0.71, 95%CI 0.49-0.79; p: 0.01)明显长于血管紧张素转换酶抑制剂/血管紧张素II受体阻滞剂(-)组。结论:联合使用肾素-血管紧张素系统抑制剂和细胞周期蛋白依赖性激酶4/6抑制剂可能对乳腺癌患者有有益的肿瘤作用,而不是心血管适应症。
{"title":"Combination of cyclin-dependent kinase 4/6 inhibitors and renin-angiotensin system inhibitors in breast cancer treatment: a promising therapeutic approach.","authors":"Emel Mutlu, Mevlüde İnanç","doi":"10.1590/1806-9282.20251164","DOIUrl":"10.1590/1806-9282.20251164","url":null,"abstract":"<p><strong>Objective: </strong>The prognosis of metastatic breast cancer has improved with new targeted therapies like cyclin-dependent kinase 4/6 inhibitors. Renin-angiotensin system inhibitors, such as direct renin inhibitors, angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors are frequently used to manage hypertension and heart failure. However, recent research indicates that they may also provide potential benefits in cancer therapy. The combination of renin-angiotensin system inhibitors with cyclin-dependent kinase 4/6 inhibitors is an emerging area of interest in cancer research. Our hypotesis that, by inhibiting angiogenesis, renin-angiotensin system inhibitors may reduce tumor growth and improve the effectiveness of cyclin-dependent kinase 4/6 inhibitors by cutting off the supply of nutrients and oxygen to the tumor.</p><p><strong>Methods: </strong>Metastatic breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors were enrolled and retrospectively divided according to angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (+) and angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (-). Progression-free survival and overall survival were defined as primary and secondary endpoints. The effect of categorized data on progression-free survival and overall survival was determined by Cox regression analyses.</p><p><strong>Results: </strong>Estimated median progression-free survival (HR 0.61, 95%CI 0.34-0.94; p = 0.041) and overall survival (HR 0.71, 95%CI 0.49-0.79; p: 0.01) were statistically significantly longer in the angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (+) group than in the angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (-) group.</p><p><strong>Conclusion: </strong>Concomitant use of renin-angiotensin system inhibitors and cyclin-dependent kinase 4/6 inhibitors may have beneficial oncological effects in patients with breast cancer beyond their cardiovascular indications.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20251164"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining the effectiveness of ChatGPT responses to frequently asked questions by individuals with postural disorders. 检查ChatGPT对姿势障碍患者常见问题的反应的有效性。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20250750
Burcu Dursun, Mustafa Savaş Torlak, Osman Tufekci

Objective: The aim of the study was to evaluate the quality and readability of ChatGPT responses to frequently asked questions by individuals with posture disorder. Providing reliable and evidence-based information about posture disorders is vital for individuals to be correctly informed.

Methods: The 10 most frequently asked questions about posture disorder were selected by two researchers from a list created by ChatGPT. The questions were transmitted to ChatGPT 4.0, and the initial responses were recorded without further follow-up questions. The quality of the responses was then assessed by five independent experts (three physiotherapists, one physical therapy and rehabilitation specialist, and one orthopedics and traumatology specialist) with a four-grade evaluation system. Readability levels were analyzed with the Flesch-Kincaid Grade Level through WordCalc software. Statistical analysis was performed using Statistical Package for the Social Sciences v29.0, and intraclass correlation coefficients were used to measure inter-rater reliability.

Results: Following a thorough evaluation of the 10 responses received, six were rated as "Excellent responses requiring no explanation," while a further four were designated as "Satisfactory responses requiring minimal explanation." The median quality score of the responses was high, indicating good alignment with current evidence-based practice. The average readability level of the responses was determined to be 8.4. Inter-rater reliability was good, with an intraclass correlation coefficients value of 0.756.

Conclusion: ChatGPT provides relatively coherent and generally readable answers to frequently asked questions about posture disorders, with most needing minimal explanation. While promising as a resource to meet the information needs of people with posture disorders, further improvements are needed to align it with personalized health needs.

目的:本研究的目的是评估ChatGPT对姿势障碍患者常见问题的回答的质量和可读性。提供有关姿势障碍的可靠和基于证据的信息对于个人正确了解至关重要。方法:两名研究人员从ChatGPT创建的列表中选择了10个最常见的姿势障碍问题。这些问题被传送到ChatGPT 4.0,最初的回答被记录下来,没有进一步的后续问题。然后由五位独立专家(三位物理治疗师,一位物理治疗和康复专家,以及一位骨科和创伤学专家)用四级评估系统评估反馈的质量。通过WordCalc软件采用Flesch-Kincaid Grade Level对可读性水平进行分析。使用Statistical Package for the Social Sciences v29.0进行统计分析,并使用类内相关系数来衡量评级间的信度。结果:在对收到的10个回答进行全面评估后,6个被评为“优秀回答无需解释”,另外4个被评为“满意回答需要最少解释”。响应的中位数质量得分很高,表明与当前循证实践良好吻合。回答的平均可读性水平确定为8.4。组间信度较好,组内相关系数为0.756。结论:ChatGPT为常见的姿势障碍问题提供了相对连贯和一般可读的答案,大多数需要最少的解释。虽然有望作为满足姿势障碍患者信息需求的资源,但需要进一步改进以使其与个性化健康需求保持一致。
{"title":"Examining the effectiveness of ChatGPT responses to frequently asked questions by individuals with postural disorders.","authors":"Burcu Dursun, Mustafa Savaş Torlak, Osman Tufekci","doi":"10.1590/1806-9282.20250750","DOIUrl":"10.1590/1806-9282.20250750","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study was to evaluate the quality and readability of ChatGPT responses to frequently asked questions by individuals with posture disorder. Providing reliable and evidence-based information about posture disorders is vital for individuals to be correctly informed.</p><p><strong>Methods: </strong>The 10 most frequently asked questions about posture disorder were selected by two researchers from a list created by ChatGPT. The questions were transmitted to ChatGPT 4.0, and the initial responses were recorded without further follow-up questions. The quality of the responses was then assessed by five independent experts (three physiotherapists, one physical therapy and rehabilitation specialist, and one orthopedics and traumatology specialist) with a four-grade evaluation system. Readability levels were analyzed with the Flesch-Kincaid Grade Level through WordCalc software. Statistical analysis was performed using Statistical Package for the Social Sciences v29.0, and intraclass correlation coefficients were used to measure inter-rater reliability.</p><p><strong>Results: </strong>Following a thorough evaluation of the 10 responses received, six were rated as \"Excellent responses requiring no explanation,\" while a further four were designated as \"Satisfactory responses requiring minimal explanation.\" The median quality score of the responses was high, indicating good alignment with current evidence-based practice. The average readability level of the responses was determined to be 8.4. Inter-rater reliability was good, with an intraclass correlation coefficients value of 0.756.</p><p><strong>Conclusion: </strong>ChatGPT provides relatively coherent and generally readable answers to frequently asked questions about posture disorders, with most needing minimal explanation. While promising as a resource to meet the information needs of people with posture disorders, further improvements are needed to align it with personalized health needs.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20250750"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adiponectin gene polymorphisms rs1501299 and rs17300539 are not associated with polycystic ovary syndrome. 脂联素基因多态性rs1501299和rs17300539与多囊卵巢综合征无关。
IF 1.3 Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.1590/1806-9282.20250864
Emre Taşkin, Semra Eroğlu

Objective: Polycystic ovary syndrome is a common and important disease that affects ovarian functions in women of reproductive age. Disease-genetic variation associations between polymorphisms of the ADIPOQ gene rs1501299 and rs17300539, and polycystic ovary syndrome were studied in several populations previously and obtained divergent results; we have investigated this association in a case-control study for the first time in the studied population.

Methods: Forty-five polycystic ovary syndrome patients and 45 control participants were enrolled. Deoxyribonucleic acid of the participants was extracted from peripheral blood. Genotyping of subjects was made according to the real-time polymerase chain reaction method using custom primers. Allele and genotype frequencies, as well as clinical characteristics, were compared between the polycystic ovary syndrome and control groups using appropriate statistical methods.

Results: The mean testosterone level of the polycystic ovary syndrome group was significantly higher than the control group after multiple testing with Bonferroni correction (p<0.001). The mean progesterone level of the control group was significantly higher than the polycystic ovary syndrome group after multiple testing with Bonferroni correction (p<0.001). There were no significant differences between groups in terms of both allele and genotype frequencies (p>0.05). According to regression analysis, neither polymorphism had any effect on having polycystic ovary syndrome (p>0.05).

Conclusion: For the first time in a sample from the studied ethnicity, we conclude that both rs1501299 and rs17300539 polymorphisms are not associated with polycystic ovary syndrome. Testosterone and progesterone levels were significantly affected by polymorphisms.

目的:多囊卵巢综合征是影响育龄妇女卵巢功能的一种常见而重要的疾病。先前在多个人群中研究了ADIPOQ基因rs1501299和rs17300539多态性与多囊卵巢综合征之间的疾病遗传变异相关性,并获得了不同的结果;我们首次在研究人群中通过病例对照研究调查了这种关联。方法:选取45例多囊卵巢综合征患者和45例对照组。从参与者的外周血中提取脱氧核糖核酸。采用定制引物,采用实时聚合酶链反应法对被试进行基因分型。采用适当的统计学方法比较多囊卵巢综合征与对照组的等位基因、基因型频率及临床特征。结果:经Bonferroni校正多次检测,多囊卵巢综合征组平均睾酮水平显著高于对照组(p0.05)。经回归分析,两种多态性对多囊卵巢综合征均无影响(p < 0.05)。结论:我们首次在研究种族的样本中得出rs1501299和rs17300539多态性与多囊卵巢综合征无关的结论。睾酮和孕酮水平受多态性显著影响。
{"title":"Adiponectin gene polymorphisms rs1501299 and rs17300539 are not associated with polycystic ovary syndrome.","authors":"Emre Taşkin, Semra Eroğlu","doi":"10.1590/1806-9282.20250864","DOIUrl":"10.1590/1806-9282.20250864","url":null,"abstract":"<p><strong>Objective: </strong>Polycystic ovary syndrome is a common and important disease that affects ovarian functions in women of reproductive age. Disease-genetic variation associations between polymorphisms of the ADIPOQ gene rs1501299 and rs17300539, and polycystic ovary syndrome were studied in several populations previously and obtained divergent results; we have investigated this association in a case-control study for the first time in the studied population.</p><p><strong>Methods: </strong>Forty-five polycystic ovary syndrome patients and 45 control participants were enrolled. Deoxyribonucleic acid of the participants was extracted from peripheral blood. Genotyping of subjects was made according to the real-time polymerase chain reaction method using custom primers. Allele and genotype frequencies, as well as clinical characteristics, were compared between the polycystic ovary syndrome and control groups using appropriate statistical methods.</p><p><strong>Results: </strong>The mean testosterone level of the polycystic ovary syndrome group was significantly higher than the control group after multiple testing with Bonferroni correction (p<0.001). The mean progesterone level of the control group was significantly higher than the polycystic ovary syndrome group after multiple testing with Bonferroni correction (p<0.001). There were no significant differences between groups in terms of both allele and genotype frequencies (p>0.05). According to regression analysis, neither polymorphism had any effect on having polycystic ovary syndrome (p>0.05).</p><p><strong>Conclusion: </strong>For the first time in a sample from the studied ethnicity, we conclude that both rs1501299 and rs17300539 polymorphisms are not associated with polycystic ovary syndrome. Testosterone and progesterone levels were significantly affected by polymorphisms.</p>","PeriodicalId":94194,"journal":{"name":"Revista da Associacao Medica Brasileira (1992)","volume":"71 12","pages":"e20250864"},"PeriodicalIF":1.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista da Associacao Medica Brasileira (1992)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1